Pharma and Life Sciences GCCs cut drug timelines by 1–2 years and drive a 5 percent decline in R&D-to-launch costs – KPMG in India & UnearthIQ Report
Hyderabad, Feb 19th: India’s Pharma and Life Sciences Global Capability Centres (GCCs) are delivering measurable gains across the drug development…
